Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00476918|
Recruitment Status : Unknown
Verified May 2007 by Heidelberg University.
Recruitment status was: Recruiting
First Posted : May 22, 2007
Last Update Posted : May 22, 2007
|Condition or disease||Intervention/treatment||Phase|
|Diabetic Retinopathy Diabetic Macular Edema||Drug: Intravitreal injection (triamcinolone acetonide)||Phase 1|
Patients with diabetic retinopathy suffer from visual acuity loss caused by diabetic macular edema. Intravitreal injected Triamcinolone Acetonide (steroid) reduces macular edema and increases visual acuity. The duration of its effect is however limited. Therefore, several injections are necessary.
In this study a dosage dependency of triamcinolone acetonide (high dosage vs low dosage) is performed. The primary outcome parameters are the number of treatments and the efficacy of each injection.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||60 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||Dosage Dependency of Intravitreal Triamcinolone Acetonide for Treatment of Diabetic Macular Edema|
|Study Start Date :||July 2006|
|Estimated Study Completion Date :||December 2007|
- Visual acuity, no of treatments, duration of efficacy [ Time Frame: 12 months ]
- intraocular pressure, retinal thickness [ Time Frame: 12 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00476918
|Contact: Ulrich HM Spandau, PhD MDemail@example.com|
|Contact: Anne Wickenhaeuser, MD||+496213832242||anne.wickenhäuser@augen.ma.uni-heidelberg.de|
|Dep of Ophthalmology, University of Mannheim||Recruiting|
|Mannheim, Germany, 68167|
|Principal Investigator: Ulrich HM Spandau, PhD MD|
|Study Director:||Jost Jonas, PhD MD||Dep of Ophthalmology, University of Mannheim|